{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 5,
        "Importance": 6,
        "Impact": 6,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 6,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Discussant of intra-lesional melanoma therapy posters said future studies must combine with PD-1s to be relevant.",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Amgen is showing resistance near $117.40.",
            "Correlation": 9,
            "Sentiment": 4,
            "Importance": 5,
            "Impact": 5,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 9,
            "Sector_Spread": 3,
            "Tech_Mentions": 8
        },
        {
            "News_content": "Amgen presents new data on Talimogene Laherparepvec as single agent and combination therapy in metastatic melanoma at ASCO.",
            "Correlation": 10,
            "Sentiment": 7,
            "Importance": 9,
            "Impact": 8,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 6,
            "Tech_Mentions": 3
        },
        {
            "News_content": "Seeking the next stock like $LXK, $AMGN, $AAPL.",
            "Correlation": 6,
            "Sentiment": 6,
            "Importance": 4,
            "Impact": 4,
            "Duration": 5,
            "Virality": 6,
            "Source_Score": 5,
            "Specificity": 5,
            "Sector_Spread": 8,
            "Tech_Mentions": 2
        }
    ]
}